We will rely on you to help lend your voice and support the biotechnology industry.
Bringing new treatments to patients, support public policies that promote innovation, improve patient access.
BIO International ConventionJune 3-6, 2019
BIO World Congress on Industrial Biotechnology and Ag TechJuly 8-11, 2019
BIO Industry Analysis Reports >>
Save. Advocate. Connect. Join Us.
A listing of all BIO members and subsidiaries.
February 11 - 12, 2019 | New York, New York
Andrew Tasker (CEO) leads the Femeda team bringing leadership to complete the R&D process and bring the product to market. Andrew has a strong background in healthcare with over 30 years experience in Pharmaceuticals, Medical Devices and Consumer Healthcare. Experience includes P&G, Boots and senior roles at Bausch and Lomb (UK commercial Director) and Pfizer Consumer Healthcare (UK Managing Director, European Director). He was the UK Managing Director and VP EMEA of Mentholatum (Rohto Pharmaceuticals). He undertook a major refocus of the business, building its international brand and strengthening the innovation pipeline to enter new category areas, doubling turnover.
His immediate role prior to Femeda was leading his own business in the development of the Puritane e-cigarette as an alternative healthcare standard nicotine replacement therapy and exclusive launch in the UK, and then selling the patent rights for a Hong V.C. to Imperial Brands in a $100m+ deal.
This speaker's sessions: